Key Details
The National HPV Vaccination Campaign, launched in February 2026, offers a free, voluntary, single-dose vaccine to 14-year-old girls at designated government health facilities, with parental consent.
National progress: More than 1 crore doses have been administered, equivalent to nearly 87% of the estimated annual target of approximately 1.2 crore girls. The target is based on Registrar General of India population estimates.
States reporting full target coverage: Gujarat, Uttar Pradesh, Andhra Pradesh, Mizoram, Madhya Pradesh and Bihar report 100% coverage of their identified target populations.
Largest numbers vaccinated: Uttar Pradesh reports more than 29.33 lakh girls vaccinated, followed by Bihar (13.70 lakh) and Gujarat (7.75 lakh).
Access and records: Parents can use U-WIN to book a slot and obtain a digital vaccination certificate. Vaccination is also available through designated government facilities.
Vaccination Offers Protection Well Before Cervical Cancer Develops
Persistent infection with certain types of human papillomavirus (HPV) causes most cervical cancer cases. Vaccinating girls at age 14 is intended to prevent infection before likely exposure, reducing their risk of cervical cancer later in life. The crore-dose milestone measures vaccinations delivered, not a reduction in cancer cases already observed.
Reported Coverage Shows Progress — and Where Follow - Up Matters
Six states have reached their identified campaign targets, while coverage reported elsewhere varies. These percentages help programme managers direct outreach, but a state reaching 100% of its identified target does not establish that every eligible girl has been found and vaccinated.
U-WIN gives health teams a way to monitor recorded vaccinations and locate coverage gaps. Frontline workers, schools and clinicians remain important for reaching families, explaining the vaccine and supporting informed parental consent.
Policy Relevance
The campaign has moved from launch to large-scale delivery. Its next measure of success is whether districts can identify eligible girls who remain unvaccinated and make access straightforward for them. That calls for examining coverage below the state level, including whether the estimated target accurately reflects the girls living in each district.
Vaccination also sits within a longer cervical-cancer prevention effort. Protection for this cohort will take years to appear in cancer statistics, while screening and care remain important for women already at risk.
Relevant Question for Policy Stakeholders: In districts reporting high coverage, how will health authorities check whether eligible girls were missed because they were absent from the identified target population?
Follow the Full Press Release Here: India Crosses 1 Crore HPV Vaccine Doses Administered